Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year ...

Shares of life sciences company Azenta (NASDAQ:AZTA) fell 16.3% in the afternoon session after the company announced mixed ...

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 3.3% in the afternoon session after an upgrade from investment ...

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Tuesday before the bell. Here’s what to look for.

Fintel reports that on August 6, 2025, Raymond James upgraded their outlook for Azenta (NasdaqGS:AZTA) from Market Perform to ...

Q3 2025 Earnings Call Transcript August 5, 2025 Azenta, Inc. misses on earnings expectations. Reported EPS is $-1.15519 EPS, expectations were $0.13. Operator: Greetings, and welcome to the Azenta Q3 ...

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable ...

Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...

FreezerPro is a web-based system that simplifies sample tracking, boosts compliance and improves lab efficiency.

BURLINGTON - Azenta, Inc. announced this week that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin ...

Evercore ISI analyst Vijay Kumar maintained a Buy rating on Enovis today and set a price target of $44.00. The company’s shares opened today at $27.58. Elevate Your Investing St ...